- Home
- / hVIVO
hVIVO
Stock Price
£0.3
2024-10-29
Market Capitalization
£180.3 M
2024-10-29
Revenue
£11 M
FY, 2018
hVIVO Summary
Company Summary
- Overview
- hVIVO is a company that specializes in human biology.
- Type
- Public
- Status
- Active
- Founded
- 1998
- HQ
- London, GB | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Cathal Friel, Chairman
Yamin ‘Mo’ Khan, Chief Executive Officer, Director
Andrew Catchpole, Chief Scientific Officer
LocationsView all
2 locations detected
London HQ
United Kingdom
New Rd
London, England
United Kingdom
2nd floor, Michaels House, 10-12 Alie St
hVIVO Financials
Summary Financials
- Revenue (H1, 2019)
- £5.9M
- Gross profit (H1, 2019)
- £1.7M
- Net income (H1, 2019)
- (£3.8M)
- Cash (H1, 2019)
- £4.0M
- EBIT (H1, 2019)
- (£4.2M)
- Enterprise value
- $179.7M